Drug Search by Year (Detail)

26494643

US

Death, Unresponsive to stimuli, Infection, Cardiac disorder, Urinary tract disorder, Haematuria, Adverse event,

NADOFARAGENE FIRADENOVEC-VNCG,

26494687

CN

Neuropathy peripheral, Infection, Intestinal obstruction, Cardiac failure, Respiratory failure, Vision blurred, Photophobia, Xerophthalmia, Gastrointestinal toxicity, Hepatic enzyme increased,

BEVACIZUMAB, MIRVETUXIMAB SORAVTANSINE,

26495206

CA

Hepatic enzyme increased, Vomiting, Nausea, Asthenia, Dysstasia, Abdominal pain upper, Infection, Drug intolerance, Inappropriate schedule of product administration, Expulsion of medication, Product use complaint,

MARALIXIBAT CHLORIDE,

26495254

CO

Intestinal obstruction, Infection,

DAROLUTAMIDE,

26495277

CA

Seizure, Localised infection, Road traffic accident, Infection, Fungal foot infection, Onychomycosis, Stress,

VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, PREDNISONE, DIVALPROEX SODIUM, MESALAMINE,

26495460

CA

Hip arthroplasty, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Joint stiffness, Knee arthroplasty, Off label use, Hypersensitivity,

ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, USTEKINUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ALENDRONATE SODIUM, APREMILAST, AZATHIOPRINE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CLONIDINE HYDROCHLORIDE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, INFLIXIMAB, INFLIXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB CITRATE, TOFACITINIB, TOFACITINIB,

26495491

AR

Infection,

TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE,

26495614

CA

Abdominal pain, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Asthenia, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, Bursitis, C-reactive protein abnormal, Chest pain, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Diarrhoea, Discomfort, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspnoea, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatic cirrhosis, Hepatic enzyme increased, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Insomnia, Intentional product use issue, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Joint swelling, Lip dry, Liver disorder, Liver injury, Lower limb fracture, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Maternal exposure timing unspecified, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nasopharyngitis, Night sweats, Obesity, Oedema, Oedema peripheral, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Prescribed overdose, Product use in unapproved indication, Product use issue, Pruritus, Psoriatic arthropathy, Pyrexia, Rash, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sciatica, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound,

TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LORAZEPAM, CAFFEINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LORAZEPAM, ERGOCALCIFEROL, TRIMETHOPRIM,

26495836

US

Surgery, Infection,

GOLIMUMAB,

26496141

EU

Infection,

PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE,

26496281

EU

Infection,

ROMIPLOSTIM, ROMIPLOSTIM,

26496474

EU

Death, Pyrexia, Infection,

PIRTOBRUTINIB,

26496665

US

Liver operation, Infection, Lymphadenopathy,

UPADACITINIB,

26500259

Hypervolaemia, Disease progression, Renal failure, Infection,

NINTEDANIB,

26500357

Pyrexia, Dizziness, Hypotension, Nausea, Chills, Urinary tract infection, Infection,

ADALIMUMAB-AATY,

26485625

US

Peripheral swelling, Infection,

VENETOCLAX, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, HYDROXYZINE, FERROUS SULFATE, LISINOPRIL, DEXLANSOPRAZOLE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, SIMVASTATIN, ICOSAPENT ETHYL, ASCORBIC ACID, PREDNISONE, ESOMEPRAZOLE MAGNESIUM, ALPRAZOLAM, DUTASTERIDE, POLYETHYLENE GLYCOL 3350,

26486955

CA

Acarodermatitis, Infection, Rash,

CEFTRIAXONE SODIUM, INFLIXIMAB,

26487029

US

Infection,

LEVONORGESTREL,

26487512

US

Arthropathy, Infection, Product dose omission issue, Product availability issue,

RUXOLITINIB,

26487745

US

Infection,

TIRZEPATIDE,

26487789

TW

Infection, Liver function test abnormal, Hepatic enzyme increased, Flushing, Pyrexia, Myalgia, Incorrect product dosage form administered,

CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, CABOZANTINIB,

26488190

Infection,

TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLIC ACID, MYCOPHENILIC ACID,

26488468

GB

Crohn^s disease, Infection, Blood test abnormal, Drug effect less than expected, Rhinorrhoea,

VEDOLIZUMAB, VEDOLIZUMAB,

26488694

US

Fluid retention, Blood iron decreased, Infection, Abdominal distension, Vision blurred, Heart rate increased, Weight increased, Nasopharyngitis, Asthenia, Brain fog, Blood creatinine abnormal,

SPARSENTAN, BUDESONIDE, PREDNISONE,

26488707

Infection, Sinusitis, Pharyngitis streptococcal, Influenza,

CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL,

26488851

UY

Infection, Pulmonary oedema,

UPADACITINIB,

26489867

CA

Blood bilirubin increased, Drug-induced liver injury, Endotracheal intubation, Infection, Pulmonary haemorrhage,

CYTARABINE, ALLOPURINOL, CALCIUM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FENTANYL, FLUCONAZOLE, DALTEPARIN SODIUM, FUROSEMIDE, HEPARIN SODIUM, HYDROXYUREA, LORAZEPAM, MIDAZOLAM HYDROCHLORIDE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PHENYLEPHRINE HYDROCHLORIDE, PROPOFOL, SEVELAMER CARBONATE, ROCURONIUM BROMIDE, ALBUTEROL SULFATE, ALBUTEROL, TRANEXAMIC ACID, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, PHYTONADIONE,

26489971

AU

Infection, Bacterial infection, Drug ineffective,

POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, TERBINAFINE HYDROCHLORIDE, TERBINAFINE, ANIDULAFUNGIN, AMPHOTERICIN B,

26490251

TH

Drug hypersensitivity, Altered state of consciousness, Hypophagia, Cough, Pyrexia, Vomiting, Infection, Fatigue,

ATEZOLIZUMAB, BEVACIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND),

26490258

EU

Infection,

RITUXIMAB, CYCLOSPORINE, SIROLIMUS,

26490333

CA

Pneumonia legionella, Respiratory tract congestion, Productive cough, Intentional product use issue, Product dose omission issue, Intentional dose omission, Product use issue, Infection, Nasopharyngitis,

ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, BRIMONIDINE, BRIMONIDINE TARTRATE, FOLIC ACID, LOTEPREDNOL ETABONATE, METHOTREXATE, METHOTREXATE SODIUM, PANTOPRAZOLE, PREDNISONE,

26490545

JP

Interstitial lung disease, Infection,

UPADACITINIB,

26490931

CA

Renal haemorrhage, Blood urine present, Nephrolithiasis, Disease progression, Infection, Wound drainage,

26490933

CA

Haematochezia, Crohn^s disease, Drug ineffective, Gastrointestinal disorder, Cholelithiasis, Infection,

PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, VEDOLIZUMAB, VEDOLIZUMAB, DUTASTERIDE, CHOLESTYRAMINE, INFLIXIMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ROSUVASTATIN, BISOPROLOL FUMARATE, AMLODIPINE,

26490942

CA

Anal fissure, Infection, Swelling, Post procedural discharge, Nasopharyngitis, Condition aggravated, Dry skin, Rash, Off label use,

PSYLLIUM HUSK, PREDNISONE,

26491140

EC

Acute kidney injury, Chronic kidney disease, Seizure, Metabolic disorder, Hypotension, Infection,

TRIENTINE TETRAHYDROCHLORIDE, TRIENTINE TETRAHYDROCHLORIDE, TRIENTINE TETRAHYDROCHLORIDE,

26491301

EU

Herpes simplex, Infection, Tinea versicolour, Drug effective for unapproved indication, Off label use,

ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP,

26491349

US

Gingivitis, Tooth extraction, Infection,

FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE,

26491543

EU

Neutropenia, Infection, Congenital aplasia,

VENETOCLAX,

26491698

US

Hypersensitivity, Infection,

AVAPRITINIB,

26493681

Influenza like illness, Inflammation, Therapy change, Fatigue, Headache, Infection, Activities of daily living decreased,

USTEKINUMAB, AMOXICILLIN,

26480317

CA

Drug level increased, Lethargy, Infection,

CLOZAPINE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, CLONAZEPAM, LITHIUM, LITHIUM BROMATUM,

26480405

EU

Inflammation, Pyrexia, Arthralgia, Diarrhoea, C-reactive protein abnormal, Infection, Inappropriate schedule of product administration, Medication error,

IXAZOMIB, HYDROCORTISONE,

26480516

AU

Bone infarction, Infection, Myositis,

MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE,

26480559

EU

Colitis ulcerative, Infection, Dry skin, Rash,

VEDOLIZUMAB, MESALAMINE,

26480619

EU

Infection, Acute kidney injury,

DURVALUMAB,

26480683

US

Insomnia, Swelling face, Infection, Dyspnoea,

RITUXIMAB, PREDNISONE, PREDNISONE, AVACOPAN,

26480867

EU

Thrombosis, Febrile neutropenia, Bacterial infection, Fungal infection, COVID-19, Infusion related reaction, Infection, Off label use,

RITUXIMAB, RITUXIMAB, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, BENDAMUSTINE HCL, BENDAMUSTINE HCL,

26480982

GB

Abdominal pain lower, Rectal haemorrhage, Chills, Pyrexia, Nausea, Infection, Appendicitis,

26481230

EU

B-cell type acute leukaemia, Minimal residual disease, Acute graft versus host disease in intestine, Acute graft versus host disease in skin, Infection,

FILGRASTIM, CYTARABINE, ETOPOSIDE, MERCAPTOPURINE, FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOSPORINE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE,

26482056

US

Illness, Infection, Drug dose omission by device, Product use in unapproved indication, Device delivery system issue,

OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE,

26482255

US

Infection,

LENALIDOMIDE,

26483344

EU

Neuroleptic malignant syndrome, Coma, Acute kidney injury, Rhabdomyolysis, Pneumonia, Haemolytic anaemia, Staphylococcal bacteraemia, Infection, Thrombophlebitis,

OLANZAPINE, LOXAPINE, LOXAPINE, LOXAPINE, LORAZEPAM, MIRTAZAPINE, OXAZEPAM, METHADONE, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL,

26483559

US

Animal bite, Infection,

DUPILUMAB,

26483685

CA

Drug intolerance, Hypogammaglobulinaemia, Infection, Neuromyelitis optica spectrum disorder, Opportunistic infection, Off label use,

RITUXIMAB, RITUXIMAB, SATRALIZUMAB, RUXOLITINIB,

26483747

GB

Infection, Diarrhoea, Fatigue, Neuropathy peripheral,

PEMBROLIZUMAB,

26483809

US

Infection, Dyspnoea, Injection site urticaria, Asthma, Musculoskeletal chest pain,

DUPILUMAB,

26483934

US

Nasopharyngitis, Infection,

TIRZEPATIDE,

26484405

Disease progression, Loss of personal independence in daily activities, Pain, Infection, Therapy interrupted, Lumbar vertebral fracture, Lumbar vertebral fracture, Lumbar vertebral fracture, Lumbar vertebral fracture,

TOFACITINIB, LEFLUNOMIDE, NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, FOLIC ACID, GABAPENTIN, PANTOPRAZOLE,

26484406

Infection, Therapy interrupted, Lumbar vertebral fracture, Lumbar vertebral fracture, Lumbar vertebral fracture,

TOFACITINIB, LEFLUNOMIDE, NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, FOLIC ACID, GABAPENTIN, PANTOPRAZOLE,

26484891

AU

Pemphigoid, Product prescribing issue, Drug ineffective, Infection, Vasculitic ulcer,

LINAGLIPTIN, DOXYCYCLINE, DOXYCYCLINE HYCLATE, NICOTINAMIDE,

26485147

EU

Abdominal pain, Infection,

26485645

Tooth impacted, Fall, Jaw fracture, Infection,

ADALIMUMAB, ADALIMUMAB, ADALIMUMAB,

26486208

Infection, Cystitis, Osteomyelitis, Drug hypersensitivity, Wrong schedule,

AVACOPAN, RIZATRIPTAN,

26475939

CA

Pneumonia bacterial, Infection, Illness, Sinusitis, Viral infection, Fatigue, Malaise, Nasal congestion,

HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G,

26476124

Atrial fibrillation, Infection, Thyroid disorder, Dry skin,

ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN,

26476325

US

Infection,

TREPROSTINIL, TREPROSTINIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FOLIC ACID, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, MELATONIN, SPIRONOLACTONE, BOSENTAN, ALBUTEROL SULFATE, ERGOCALCIFEROL, SOTATERCEPT-CSRK, TADALAFIL, DIGOXIN, MAGNESIUM, ONDANSETRON HYDROCHLORIDE, VITAMIN C,

26476450

MY

Pyrexia, Infection, Therapy interrupted,

ANIFROLUMAB-FNIA,

26476477

US

Immune system disorder, Muscular weakness, Myasthenia gravis, Loss of personal independence in daily activities, Asthenia, Dysphagia, Infection,

RAVULIZUMAB,

26476547

Infection, Upper respiratory tract infection,

LENIOLISIB, QUETIAPINE, VALACYCLOVIR HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, HUMAN IMMUNOGLOBULIN G,

26476548

US

Infection,

C1 ESTERASE INHIBITOR RECOMBINANT,

26476715

US

Product use issue, Infection, Lymphadenopathy, Fatigue, Weight decreased, Decreased appetite, Depression, Thyroid disorder, Tremor, Muscular weakness, Hypoaesthesia,

26476800

US

Infection,

VIGABATRIN,

26476871

US

Hip surgery, Hypophagia, Infection, Lymphocytic leukaemia,

IBRUTINIB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, GABAPENTIN, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, RIVAROXABAN, ERGOCALCIFEROL, ZINC, ZINC GLUCONATE, ZINC CHLORIDE,

26476876

AU

Infection, Systemic infection, Haematological infection, Gastrointestinal infection, Skin infection, Respiratory tract infection, Genital infection, Bacterial infection, Viral infection, Fungal infection, Bacteraemia, Klebsiella infection, Urinary tract infection,

FILGRASTIM, CYTARABINE, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE,

26477183

ZA

Cushing^s syndrome, Growth retardation, Infection,

MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, AZATHIOPRINE, CYCLOSPORINE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, RITUXIMAB,

26479091

CA

Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Insomnia,

RITUXIMAB,

26479095

GB

Multiple organ dysfunction syndrome, Septic shock, Gastrointestinal haemorrhage, Hepatic fibrosis, Oesophageal varices haemorrhage, Portal hypertension, Infection, Myocardial ischaemia, Emphysema, Varices oesophageal, Pneumonia fungal, Psoriatic arthropathy,

METHOTREXATE, METHOTREXATE SODIUM,

26479180

US

Infection,

HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G,

26479608

US

End stage renal disease, Seizure, Pneumonia, Malignant hypertension, Posterior reversible encephalopathy syndrome, Atypical haemolytic uraemic syndrome, Thrombotic microangiopathy, Glomerulonephritis rapidly progressive, Treatment noncompliance, Central nervous system lesion, Infection, Headache, Vasculitis, Cerebral disorder, Off label use,

RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, RAVULIZUMAB,

26479907

GB

Intermenstrual bleeding, Ovarian cyst, Menstrual disorder, Infection, Lymphadenopathy, Spondyloarthropathy,

IXEKIZUMAB, IXEKIZUMAB,

26480051

GB

Pancreatitis acute, Pancreatitis necrotising, Infection, Pyrexia, Abdominal pain upper, Vomiting, Flatulence, Abdominal distension,

TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, DAPAGLIFLOZIN, DAPAGLIFLOZIN, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, MIRTAZAPINE, MIRTAZAPINE, MOMETASONE, MOMETASONE, RAMIPRIL, RAMIPRIL,

26480200

EU

Weight decreased, Diarrhoea, Chills, Nausea, Vomiting, Dyspnoea exertional, Feeding disorder, Infection,

AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW, AMIVANTAMAB-VMJW,

26471482

US

Infection,

NATALIZUMAB,

26471555

CA

Abdominal discomfort, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Asthenia, Asthma, Autoimmune disorder, Blood cholesterol increased, C-reactive protein, C-reactive protein abnormal, Chest pain, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Diarrhoea, Discomfort, Drug hypersensitivity, Dry mouth, Duodenal ulcer perforation, Dyspnoea, Fatigue, Fibromyalgia, Folliculitis, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Irritable bowel syndrome, Joint swelling, Lip dry, Liver disorder, Maternal exposure during pregnancy, Pemphigus, Off label use, Therapeutic product effect decreased,

TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE,

26472025

US

Mouth haemorrhage, Infection, Blister, Follicular lymphoma recurrent, Nail discolouration,

RITUXIMAB, RITUXIMAB,

26472162

US

Infection,

LENALIDOMIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCIUM CARBONATE, ANTACID, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CHLORPHENIRAMINE MALEATE, FAMOTIDINE, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, OXYCODONE, PROCHLORPERAZINE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE,

26472259

US

Puerperal infection, Haemolysis, Exposure during pregnancy, Off label use, Infection,

RAVULIZUMAB,

26472402

US

Infection, Pneumonia, Pyrexia, Catheter placement,

DULAGLUTIDE, HUMAN INSULIN, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, INSULIN GLARGINE, CARBOXYMETHYLCELLULOSE SODIUM, PREDNISONE, PROPRANOLOL HYDROCHLORIDE, ALLOPURINOL, ALBUTEROL SULFATE, AMMONIUM LACTATE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, SIMVASTATIN, FISH OIL, HYDRALAZINE HYDROCHLORIDE, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, PARICALCITOL, ERGOCALCIFEROL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, BUDESONIDE,

26472667

US

Aphonia, Hypotension, Fatigue, Clostridium difficile infection, Inflammatory marker decreased, Pancreatitis, Infection, Burn of internal organs,

RISANKIZUMAB-RZAA, MAGNESIUM,

26472805

GB

Infection, Neurological symptom, Diarrhoea, Dysphagia, Cardiac failure, Facial paralysis, Hypoaesthesia, Paralysis, Pulmonary function test,

PEMBROLIZUMAB,

26472900

CN

Myelosuppression, Pyrexia, C-reactive protein increased, Pain, Infection,

CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, RITUXIMAB, RITUXIMAB, EPIRUBICIN HYDROCHLORIDE, POLATUZUMAB VEDOTIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS,

26472908

CA

Flank pain, Staphylococcal infection, Weight increased, Impaired healing, Nausea, Renal disorder, Hypertension, Obesity, Renal impairment, Blood creatinine increased, Hallucination, auditory, Haemoglobin decreased, Memory impairment, Pain, Thermal burn, Wound, Diarrhoea, Burning sensation, Haematocrit decreased, Hallucination, visual, Infection, Wound complication, Hallucinations, mixed, Toxicity to various agents,

QUETIAPINE FUMARATE, QUETIAPINE, ARIPIPRAZOLE, ALPRAZOLAM, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BUPROPION, PIROXICAM, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, OLANZAPINE, SERTRALINE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, RISPERIDONE, SERTRALINE, DIVALPROEX SODIUM, QUETIAPINE FUMARATE, QUETIAPINE,

26472968

US

Infection,

POMALIDOMIDE, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL BISULFATE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HYDROCLORIDE, MELATONIN, OMEGA-3-ACID ETHYL ESTERS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PANTOPRAZOLE, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, ORAL SEMAGLUTIDE, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, ERGOCALCIFEROL,

26473032

CA

Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blister, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Discomfort, Duodenal ulcer perforation, Dyspnoea, Fatigue, Folliculitis, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint swelling, Lower respiratory tract infection, Muscle injury, Nasopharyngitis, Pain, Pemphigus, Pericarditis, Peripheral swelling, Pruritus, Pyrexia, Rash, Rheumatoid arthritis, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Weight increased, Wound,

RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB,

26473682

JP

Infection, Neutropenia, Nephropathy toxic, Hepatotoxicity, Drug eruption, Disease progression, Drug ineffective,

RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM,

26473947

EU

Treatment failure, Pneumonia, Arrhythmia, Hypertension, Cardiac failure, Infection, Hyperglycaemia, Confusional state,

ALTEPLASE,

26474122

JP

Chronic respiratory failure, Infection,

NINTEDANIB,

26474184

US

Infection,

TOBRAMYCIN, TOBRAMYCIN SOLUTION, TOBRAMYCIN SULFATE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, ALBUTEROL SULFATE,

26474197

US

Infection, Cystic fibrosis,